IL5 and COVID-19: The presence of chronic inflammation in hypertensive patients may explain our observation of increased circulating levels of IL-4, IL-5, IL-13, IL-17A, and TNF-β levels during hospitalization in patients with COVID-19 and hypertension in the present study.